Advertisement

Clinical Drug Investigation

, Volume 27, Issue 7, pp 505–508 | Cite as

Successful Treatment of Propafenone, Digoxin and Warfarin Overdosage with Plasma Exchange Therapy and Rifampicin

  • Sule Unal
  • Benan Bayrakci
  • Umit Yasar
  • Tevfik Karagoz
Case Report

Abstract

We report here the successful treatment of a 16-year-old female who ingested 20 tablets of digoxin each containing 0.25mg (total dose ingested equivalent to 0.1 mg/kg), 32 tablets of warfarin each containing 5mg (equivalent to 3.2 mg/kg), and approximately 15 tablets of propafenone each containing 300mg (equivalent to 90 mg/kg). The patient developed hypotension and sinus bradycardia necessitating external cardiac pacing 17 hours after drug ingestion. In addition to gastric lavage, activated charcoal, blood alkalinisation, administration of vitamin K and temporary cardiac pacing, the authors performed plasma exchange for drug removal and administered rifampicin in order to increase the metabolism of digoxin, propafenone and warfarin. The patient was discharged without any sequelae. Plasma exchange may be lifesaving in drug ingestions where there is a low volume of distribution and high plasma protein binding. Rifampicin, an inducer of cytochrome p450, may be used in intoxications for elimination of drugs with inactive metabolites.

Keywords

Warfarin Digoxin Rifampicin International Normalise Ratio Plasma Exchange 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

No sources of funding were used to assist in the preparation of this report. The authors have no conflicts of interest that are directly relevant to the content of this report.

References

  1. 1.
    Smith JW, Weinstein R. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003; 43: 820–2PubMedCrossRefGoogle Scholar
  2. 2.
    Klemmel PJ, Chalermskulrat W, Reif MS, et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small vessel vasculitis. Am J Kidney Dis 2003; 42: 1149–53CrossRefGoogle Scholar
  3. 3.
    Lennertz A, Parhofer KG, Samtleben W, et al. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther Apher 1999; 3: 227–33PubMedCrossRefGoogle Scholar
  4. 4.
    Bosch T, Buhmann R, Lennertz A, et al. Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation. Ther Apher 1999; 3: 252–6PubMedCrossRefGoogle Scholar
  5. 5.
    Furlan M, Lammle B. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura: new insights into underlying biochemical mechanisms. Nephrol Dial Transplant 2000; 15: 1112–4PubMedCrossRefGoogle Scholar
  6. 6.
    Dau PC, Lindstrom JM, Cassel CK, et al. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977; 297: 1134–40PubMedCrossRefGoogle Scholar
  7. 7.
    Samtleben W, Mistry-Burchardi N, Hartmann B, et al. Therapeutic plasma exchange in the intensive care setting. Ther Apher 2001; 5: 351–7PubMedCrossRefGoogle Scholar
  8. 8.
    Official propafenone FDA information [online]. Available from: http://www.drugs.com/pro/PROPAFENONE.html [Accessed 2007 Mar 30]
  9. 9.
    Hauptman PJ, Kelly RA. Digitalis. Circulation 1999; 99: 1265–70PubMedCrossRefGoogle Scholar
  10. 10.
    Cruickshank J, Ragg M, Eddey D. Warfarin toxicity in the emergency department: recommendations for management. Emerg Med (Fremantle) 2001; 13: 91–7CrossRefGoogle Scholar
  11. 11.
    Andiran N, Sarikayalar F. Pattern of acute poisonings in childhood in Ankara: what has changed in twenty years? Turk J Pediatr 2004; 46: 147–2PubMedGoogle Scholar
  12. 12.
    Calvo MV, Martin-Suarez A, Martin Luengo C, et al. Interaction between digoxin and propafenone. Ther Drug Monit 1989; 11: 10–5PubMedCrossRefGoogle Scholar
  13. 13.
    Bigot MC, Debruyne D, Bonnefoy L, et al. Serum digoxin levels related to plasma propafenone levels during concomitant treatment. J Clin Pharmacol 1991; 31: 521–6PubMedGoogle Scholar
  14. 14.
    Kates RE, Yee YG, Kirsten EB. Interaction between warfarin and propafenone in healthy volunteer subjects. Clin Pharmacol Ther 1987; 42: 305–11PubMedCrossRefGoogle Scholar
  15. 15.
    Sketris IS, Parker WA, Jones JV. Effect of plasma exchange on drug removal. In: Valbonesi M, Pineda AA, Biggs JC, editors. Therapeutic hemapheresis. Milan, Italy: Wichtig Editore, 1986: 15–20Google Scholar
  16. 16.
    Zdunek M, Mitra A, Mokrzycki MH. Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance. Am J Kidney Dis 2000; 36: 177–83PubMedCrossRefGoogle Scholar
  17. 17.
    Henze T, Prange HW, Talartschik J, et al. Complications of plasma exchange in patients with neurological diseases. Klin Wochenschr 1990; 68: 1183–8PubMedCrossRefGoogle Scholar
  18. 18.
    Harder S, Thurmann P. Clinically important drug interactions with anticoagulants: an update. Clin Pharmacokinet 1996; 30: 416–44PubMedCrossRefGoogle Scholar
  19. 19.
    Niemi M, Backman JT, Fromm MF, et al. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003; 42: 819–50PubMedCrossRefGoogle Scholar
  20. 20.
    Yamamoto T, Suzuki A, Kohno Y. High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes. Xenobiotica 2003; 33: 823–39PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Authors and Affiliations

  • Sule Unal
    • 1
  • Benan Bayrakci
    • 2
  • Umit Yasar
    • 3
  • Tevfik Karagoz
    • 4
  1. 1.Department of Pediatrics, Division of Pediatric HematologyHacettepe University, Faculty of MedicineAnkaraTurkey
  2. 2.Department of Pediatrics, Division of Pediatric Intensive CareHacettepe University, Faculty of MedicineAnkaraTurkey
  3. 3.Department of PharmacologyHacettepe University, Faculty of MedicineAnkaraTurkey
  4. 4.Department of Pediatrics, Division of Pediatric CardiologyHacettepe University, Faculty of MedicineAnkaraTurkey

Personalised recommendations